News
-
-
PRESS RELEASE
PharmaSGP with significant increase in revenues and EBITDA in 2024
PharmaSGP Holding SE achieved significant revenue and EBITDA growth in 2024. Revenues increased by 17.5% to €118.8 million, with adjusted EBITDA reaching €37.2 million. Management foresees further growth in 2025 amidst global uncertainty -
-
PRESS RELEASE
ECOSLOPS : RESULTATS ANNUELS 2024 ET REAMENAGEMENT DE LA DETTE
Ecoslops annonce les résultats annuels 2024 et le réaménagement de sa dette financière avec un chiffre d'affaires en progression de 12% et un EBITDA positif. Faits marquants : vente d'Ecoslops Provence, résultats satisfaisants au Portugal, plan d'économies, réduction de la dette nette -
-
-
PRESS RELEASE
Cicor is continuing to grow in double digits – successful integration and M&A activities are strengthening the growth trend
Cicor Group reports strong Q1 results with 22.2% sales growth to CHF 131.1 million fueled by successful mergers & acquisitions. Company continues executing growth strategy -
-
-